Search

Search Results

• Endometriosis and ovarian cancer - what they have in common?

  Natalia Zarankiewicz, Katarzyna Kosz, Aleksandra Kuchnicka, Martyna Zielińska, Natalia Wolanin, Bogumiła Ciseł

  230-239

  2020-08-17
• Targeted therapy with Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of solid tumours

  Faustyna Piędel, Agata Agnieszka Rocka, Klaudia Daria Szumna, Dominika Katarzyna Madras, Patryk Piotr Jasielski

  133-139

  2020-03-27
• Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report

  Aleksandra Obuchowska, Arkadiusz Standyło, Alicja Ozga, Justyna Wójcik, Karolina Obuchowska, Paweł Skorupski

  84-91

  2020-09-04
• Key trends in morbidity and mortality rate due to ovarian cancer in Ukraine

  M. Romaniv, N. Terenda

  138-145

  2023-05-31
• Quality of life in patients with advanced ovarian cancer under personalised treatment: the impact of HIPEC

  V. Maksymovskyi, A. Rybin, V. Zamyshlyak

  64751

  2025-08-11
• PARP Inhibitors in the Treatment of Ovarian Cancer a review of the latest research

  Andrzej Paweł Zuzak, Małgorzata Satora, Magdalena Cieślik-Porębska, Krzysztof Kułak, Jagoda Niewiadomska

  57677

  2025-02-21
• The latest reports on biomarkers used in the diagnosis of ovarian cancer

  Aleksandra Chałupnik, Zuzanna Chilimoniuk, Maciej Dobosz, Anna Sobstyl, Małgorzata Sobstyl

  799-809

  2022-08-02
• Diagnostic challenges in the diagnosis and treatment of ovarian cancer in Lynch syndrome

  Agnieszka Protasiuk, Agata Żak, Rafał Sierzpowski, Patrycja Tymoszuk, Bartosz Kasperek, Katarzyna Augustowska

  56840

  2025-01-03
• Fertility Preservation Strategies in Cancer Patients: A Comprehensive Review

  Michał Razik, Piotr Bator, Patrycja Rozwadowska, Jan Ramian, Jakub Rybak, Barbara Magiera, Karol Magiera, Wiktor Razik

  129-139

  2024-02-19
• The role of soy in development of breast, ovarian, endometrial and prostate gland cancer

  Marcela Maksymowicz, Piotr Machowiec, Natalia Baran, Małgorzata Piekarska

  180-186

  2021-09-11
• Роль гомеостатистических механизмов в формировании результативности платинолечения больных с раком яичника = Role homeostatistic mechanisms in the formation of performance platinum treatment of patients with ovarian cancer

  A. I. Rybin

  405-414

  2016-06-17
• Ketogenic diet for ovarian disorders - promising nutritional approach in polycystic ovarian syndrome and ovarian cancer

  Magda Wojtuś, Sebastian Tomaszuk, Karolina Wąsik

  49846

  2024-04-12
• Mechanisms of drug resistance in ovarian cancer

  Klaudia Żak, Michał Piwoński, Paweł Stanicki, Karolina Kalicka, Justyna Nowaczek

  362-367

  2021-09-21
• Особенности процессов детоксикации у больных раком яичника с разной чувствительностью к препаратам платины = Features detoxification process ovarian cancer patients with different sensitivity to platinum drugs

  A. I. Ribin

  686-690

  2015-12-31
• Роль цикла оксида азота в формировании особенностей течения рака яичника = Role of nitrogen oxide cycle in the formation features of the current ovarian cancer

  A. Ribin

  399-404

  2015-11-25
• Current ideas about molecular genetic subtypes of ovarian cancer: a personalized approach and a new platform for further research

  A. Rybin

  157-168

  2021-11-26
• An overview of endometrial cancer risk factors

  Piotr Żychoń , Eryk Prajwos , Kamil Janawa, Michał Tomaszek , Małgorzata Domagała, Klaudia Cękalska, Wiktoria Stenka

  56569

  2024-12-20
• Risk factors of ovarian cancer: family history, obesity and oral contraceptive use

  Aleksandra Amalia Kuchnicka, Martyna Zielińska, Natalia Zarankiewicz, Katarzyna Kosz, Halina Piecewicz-Szczęsna

  397-402

  2020-09-18
• Sexuality and fertility of young women suffering from breast cancer

  Martyna Zielińska, Natalia Zarankiewicz, Katarzyna Kosz, Aleksandra Kuchnicka, Jakub Aleksandrowicz, Katarzyna Książek, Sylwia Mojsym-Korybska

  775-785

  2019-08-02
• Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer

  A. I. Rybin, V. Y. Maksymovskyj, V. V. Pyrogov, R. Ya. Demidchik, A. O. Varabina

  412-417

  2018-10-31
• Opportunistic salpingectomy versus tubal ligation. A review of current strategies for ovarian cancer prevention

  Aleksandra Anna Miciak, Aleksandra Karolina Węglarz, Patrycja Anna Borowiecka, Jagoda Anna Adamarczuk, Jacek Głuski, Nina Urantówka, Aleksandra Wojtera, Marta Omiecińska, Karina Barbara Kaszowska, Tomasz Piotr Dąbrowski, Karolina Kaczmarz-Chojnacka

  69445

  2026-03-17
• Selected effects of combined oral contraceptives use

  Julia Bogucka, Anna Brzyska, Natalia Domańska, Małgorzata Bojarska, Natalia Wilczek, Halina Piecewicz-Szczęsna

  259-272

  2022-08-31
• Vitamin A - potential anticancer weapon

  Natalia Aleksandra Popławska, Justyna Śliz, Marta Skorupska, Magdalena Joanna Czeczotka, Krzysztof Woźniak

  51511

  2024-05-30
• The quality of life of patients with ovarian cancer as an indicator of functional assessing the effectiveness of anticancer therapy

  O. O. Kolesnik, A. I. Rybin

  539-551

  2017-05-31
• Synchronous borderline ovarian tumor with endometrioid endometrial carcinoma - from diagnosis to treatment. A Case study

  Eliza Kolasa, Alicja Paluch, Krzysztof Kułak

  48-58

  2023-06-21
• Clinical differentiation between ovarian granulosa cell tumor and ovarian cancer: a review

  Małgorzata Chyćko, Julia Czarnota, Katarzyna Cichoń, Nina Lasota, Maciej Lambach, Martyna Younes, Gabriela Demidowicz, Wojciech Wiśniewski, Klaudia Kowalczyk, Natalia Trąbka

  105-113

  2023-10-27
• The Modern Approaches and Future Perspectives on Breast and Ovarian Cancer Prevention Strategies in BRCA1 and BRCA2 Mutation Carriers: A Literature Overview

  Sandra Sarnacka, Jakub Kordialik, Julia Koćwin, Paula Bieganek, Bartosz Sadłowski, Stanisław Łukaszewicz, Piotr Pawłowski, Julia Rybak, Michał Tokarski, Angelika Banasiak

  49454

  2024-05-16
• Modern strategies of platinum resistance overcoming in patients with the serous ovarian cancer

  Andriy Rybin

  594-599

  2018-11-30
• Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation

  Anna Rodzajewska, Weronika Kuryło, Katarzyna Szklener

  138-147

  2023-08-08
• Biomarkers of platinum resistance in serous ovarian cancer

  A. Rybin

  65774

  2025-09-25
• Ovarian tumors - epidemiology, diagnosis and prevention in Poland

  Agata Ulenberg, Grzegorz Ulenberg

  299-310

  2018-11-16
• Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches

  A. Rybin, V. Maksymovskyi, O. Kuznetsova, V. Zamyshlyak

  64576

  2025-06-30
• Endometriosis and an increased risk of malignancies

  Aleksandra Maria Krasa, Magdalena Kozioł, Halina Piecewicz-Szczęsna, Mateusz Pawlicki, Anna Łopuszyńska, Paulina Krawiec, Ewa Piekarska

  290-298

  2020-09-12
• Clinical significancy of WNT pathway inhibition in various cancers

  Patryk Rogaczewski, Michał Janiak , Kamil Borysewicz, Tadeusz Głos, Navid Ahmadi, Łukasz Szylberg

  183-191

  2022-11-03
• Results of treatment of cancer patients with peritoneal carcinomatosis

  O. Bondar, A. Rybin, A. Varabina

  304-314

  2022-05-31
• Have thyroid hormones an impact on ovarian cancer?

  Klaudia Żak, Sylwiusz Niedobylski, Milena Leziak, Karolina Maliszewska, Mirella Czapska, Katarzyna Skórzyńska-Dziduszko

  803-809

  2018-12-31
• TIMP way to stop metastasis?

  Katarzyna Jarosz, Robert Chudzik, Maria Gołębiowska, Beata Gołębiowska

  598-604

  2017-08-03
• Bisophosphonates in the treatment of osteoporosis in women with breast cancer

  Joanna Wolska

  357-363

  2019-09-09
• When endometrioma becomes malignant: a clinical case and conclusions for oncogynecological practice

  Andriy Rybin, Sergiy Liskovskyi

  67343

  2025-12-11
• Endometriosis: Pathogenesis, diagnosis, treatment and the role of gut microbiota

  Hanna Senat, Patrycja Grabowska, Aleksandra Senat, Patrycja Bolla, Aleksandra Madej, Zuzanna Marczyńska, Karolina Libracka

  87-101

  2024-02-13
• Anticancer properties of berberine - analysis of the latest reports

  Patrycja Rozwadowska, Piotr Bator, Michał Razik, Jan Ramian, Jakub Rybak, Barbara Magiera, Karol Magiera, Wiktor Razik

  73-86

  2024-02-16